1. Home
  2. BLND vs BVS Comparison

BLND vs BVS Comparison

Compare BLND & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLND
  • BVS
  • Stock Information
  • Founded
  • BLND 2012
  • BVS 2011
  • Country
  • BLND United States
  • BVS United States
  • Employees
  • BLND N/A
  • BVS N/A
  • Industry
  • BLND EDP Services
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BLND Technology
  • BVS Health Care
  • Exchange
  • BLND Nasdaq
  • BVS Nasdaq
  • Market Cap
  • BLND 917.8M
  • BVS 883.7M
  • IPO Year
  • BLND 2021
  • BVS 2021
  • Fundamental
  • Price
  • BLND $5.22
  • BVS $11.51
  • Analyst Decision
  • BLND Buy
  • BVS Strong Buy
  • Analyst Count
  • BLND 7
  • BVS 2
  • Target Price
  • BLND $4.17
  • BVS $16.00
  • AVG Volume (30 Days)
  • BLND 2.6M
  • BVS 494.5K
  • Earning Date
  • BLND 11-06-2024
  • BVS 11-05-2024
  • Dividend Yield
  • BLND N/A
  • BVS N/A
  • EPS Growth
  • BLND N/A
  • BVS N/A
  • EPS
  • BLND N/A
  • BVS N/A
  • Revenue
  • BLND $156,715,000.00
  • BVS $555,061,000.00
  • Revenue This Year
  • BLND $5.56
  • BVS $11.24
  • Revenue Next Year
  • BLND $22.08
  • BVS $6.77
  • P/E Ratio
  • BLND N/A
  • BVS N/A
  • Revenue Growth
  • BLND N/A
  • BVS 10.40
  • 52 Week Low
  • BLND $1.21
  • BVS $3.77
  • 52 Week High
  • BLND $5.29
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • BLND 75.14
  • BVS 45.14
  • Support Level
  • BLND $4.07
  • BVS $10.92
  • Resistance Level
  • BLND $4.75
  • BVS $11.75
  • Average True Range (ATR)
  • BLND 0.34
  • BVS 1.00
  • MACD
  • BLND 0.10
  • BVS -0.12
  • Stochastic Oscillator
  • BLND 95.76
  • BVS 59.46

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: